“Perfect Patient” Industry Burdens; Exits and Investment in Women’s Health
BioSpace · BioSpace
Audio is streamed directly from the publisher (api.riverside.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Miruna Sasu, CEO of COTA, has been labeled as a disrupter in the industry. In this episode, she discusses the challenges of stringent inclusion and exclusion criteria of clinical trials. She also dives into her main takeaways from this year's JP Morgan Healthcare Conference and Scope Summit around exits and investment in women's health.
Host
Lori Ellis, Head of Insights, BioSpace
Guests
Miruna Sasu, President and CEO, COTA
Disclaimer: The views expressed in this discussion by guests are their own and do not represent those of their organizations.